Vaishali Pharma Ltd. | Small-cap | Healthcare
₹12.41
0.65%
| Vaishali Pharma Stock Comparison:
Vaishali Pharma vs Sun PharmaceuticalVaishali Pharma vs Divi's LaboratoriesVaishali Pharma vs Sun Pharma AdvancedVaishali Pharma vs Aarti DrugsVaishali Pharma vs Sequent ScientificVaishali Pharma vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2024

Income Metrics

Revenue 279.1M
Gross Profit 41.8M 14.97%
Operating Income 12.4M 4.46%
Net Income 14.4M 5.17%
EPS (Diluted) ₹0.98

Balance Sheet Metrics

Total Assets 1.0B
Total Liabilities 361.9M
Shareholders Equity 677.6M
Debt to Equity 0.53

Cash Flow Metrics

Revenue & Profitability Trend

Vaishali Pharma Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i817.6M638.2M715.4M523.1M584.1M
Cost of Goods Sold i744.2M546.8M635.0M461.5M510.9M
Gross Profit i73.5M91.5M80.4M61.6M73.2M
Gross Margin % i9.0%14.3%11.2%11.8%12.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i10.3M9.1M5.0M4.7M5.5M
Other Operating Expenses i16.6M25.2M27.5M8.1M13.8M
Total Operating Expenses i26.9M34.3M32.5M12.8M19.3M
Operating Income i63.4M89.7M64.8M40.4M46.3M
Operating Margin % i7.8%14.1%9.1%7.7%7.9%
Non-Operating Items
Interest Income i13.9M12.6M13.0M12.6M13.1M
Interest Expense i22.7M22.6M24.9M26.3M25.6M
Other Non-Operating Income-----
Pre-tax Income i9.3M88.5M57.3M14.0M791.1K
Income Tax i2.1M22.4M17.0M3.6M463.2K
Effective Tax Rate % i22.4%25.4%29.8%25.5%58.6%
Net Income i7.2M66.0M40.2M10.5M327.8K
Net Margin % i0.9%10.3%5.6%2.0%0.1%
Key Metrics
EBITDA i87.9M116.1M86.7M62.8M72.4M
EPS (Basic) i₹0.07₹0.63₹0.38₹0.10₹0.00
EPS (Diluted) i₹0.06₹0.59₹0.38₹0.10₹0.00
Basic Shares Outstanding i106165420105462130105462130105462130105462130
Diluted Shares Outstanding i106165420105462130105462130105462130105462130

Income Statement Trend

Vaishali Pharma Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i14.6M5.3M11.6M3.1M2.8M
Short-term Investments i121.3M118.9M120.5M119.7M-
Accounts Receivable i494.3M536.1M585.1M667.3M470.3M
Inventory i3.8M30.5M6.3M5.9M8.8M
Other Current Assets-1.0K10.0K1.0K-1-
Total Current Assets i745.2M726.7M764.3M813.0M613.1M
Non-Current Assets
Property, Plant & Equipment i14.6M18.0M9.0M9.7M0
Goodwill i8.0M8.6M7.7M2.9M4.0M
Intangible Assets i8.0M8.6M7.7M2.9M4.0M
Long-term Investments-----
Other Non-Current Assets-2.0K1.0K1.0K11
Total Non-Current Assets i54.4M62.3M52.0M48.3M49.0M
Total Assets i799.6M789.0M816.2M861.3M662.0M
Liabilities
Current Liabilities
Accounts Payable i193.9M180.0M283.8M405.4M217.3M
Short-term Debt i96.6M86.3M176.7M135.9M127.8M
Current Portion of Long-term Debt-----
Other Current Liabilities36.9M-1.0K15.2M114.5M
Total Current Liabilities i330.8M320.7M519.4M592.6M404.2M
Non-Current Liabilities
Long-term Debt i38.3M61.1M31.4M42.6M42.7M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities2.0K1.0K1.0K2-
Total Non-Current Liabilities i40.3M63.0M33.3M44.4M44.1M
Total Liabilities i371.2M383.7M552.7M637.1M448.2M
Equity
Common Stock i107.2M105.5M105.5M105.5M105.5M
Retained Earnings i149.1M141.9M75.9M35.7M25.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i428.4M405.3M263.5M224.2M213.8M
Key Metrics
Total Debt i134.9M147.4M208.1M178.5M170.4M
Working Capital i414.4M406.0M244.9M220.3M208.9M

Balance Sheet Composition

Vaishali Pharma Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i9.3M88.5M57.3M14.0M791.1K
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i25.4M40.0M70.9M-202.3M3.4M
Operating Cash Flow i37.2M135.0M139.8M-176.2M15.9M
Investing Activities
Capital Expenditures i-1.1M-3.0M-8.6M-1.3M-526.0K
Acquisitions i-----
Investment Purchases i--00-
Investment Sales i-----
Investing Cash Flow i-1.1M-3.0M-8.6M-1.3M-526.0K
Financing Activities
Share Repurchases i---1.0M0-
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i18.5M-17.3M49.7M-13.1K1.4M
Free Cash Flow i7.0M7.8M4.5M18.9M31.7M
Net Change in Cash i54.5M114.7M180.8M-177.5M16.8M

Cash Flow Trend

Vaishali Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 214.50
Price to Book 2.57
Price to Sales 1.65
PEG Ratio -2.41

Profitability Ratios

Profit Margin 0.83%
Operating Margin -18.32%
Return on Equity 1.52%
Return on Assets -0.26%

Financial Health

Current Ratio 2.61
Debt to Equity 18.98
Beta 0.35

Per Share Data

EPS (TTM) ₹-1.55
Book Value per Share ₹4.79
Revenue per Share ₹7.31

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
vaishali1.6B214.502.571.52%0.83%18.98
Sun Pharmaceutical 3.8T36.635.2715.08%19.29%3.26
Divi's Laboratories 1.6T68.7110.5914.64%23.89%0.03
Sun Pharma Advanced 46.3B-13.52-21.31157.88%-53.22%-1.24
Aarti Drugs 44.6B23.663.2612.28%7.80%44.92
Sequent Scientific 42.0B195.405.964.35%1.41%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.